To cite this paper use one of the standards below:
Carnosine is an endogenous dipeptide and deserves huge interest due to its biological and chemical properties, particularly its role as a chelate of metal ions and antioxidant agent. Antioxidant agents are essential in suppressing oxidative damage to biomolecules caused mainly by reactive species, although produced by physiological processes, they are also active in many pathogeneses such as neurodegenerative disorders. Evidence suggests that carnosine may act in therapy for many diseases, however, current research reports the use of carnosine in high concentrations and prolonged incubation period for in vitro assays to achieve significant IC50 values in anticancer studies. Consequently, there is a demand for more potent carnosine analogues with improved biochemical properties. This study investigates the possible therapeutic potential of carnosine derivatives. The principal aim is to evaluate their efficacy in inhibiting the aggregation of Aβ1-40 peptides.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper